|
|
| | | | | | Dear colleagues,
| | | | | | | | We are already looking forward to the International Symposium on Hodgkin Lymphoma (ISHL13) which will take place in the Gürzenich Hall Conference Center in Cologne, Germany, from October 26 to 28, 2024.
| | | | | | | | The Scientific Committee of the ISHL13 has been established and will soon discuss and finalise the scientific program. It will provide an overview of the latest advances in biology, clinical research, diagnostics and treatment of Hodgkin Lymphoma. In addition, an educational track focusing on “Emerging Therapeutic Concepts in B-Cell Lymphomas” will complement the ISHL13 program.
| | | | | | | | The abstract submission and early bird registration will be opened early 2024.
| | | | | | | | For more information, please visit our homepage.
| | | | | |
|
| | We look forward to meeting you for ISHL13 in Cologne in 2024.
| | | | | | | | Peter Borchmann, MD,
Symposium and GHSG Chairman | |
Sven Borchmann, MD,
Symposium Co-Chair | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
| | | | |
|
 |
|
|
